MedPath

Physical Performance Testing and Frailty in Prediction of Early Postoperative Course After Cardiac Surgery

Active, not recruiting
Conditions
Cardiac Surgery
Rehabilitation
Frailty
Physical Performance
Registration Number
NCT05166863
Lead Sponsor
Jan Gofus, MD, PhD
Brief Summary

Standard risk prediction models in cardiac surgery (such as EuroSCORE II or STS score) are designed to analyze solely the risk of short-term postoperative mortality. The postoperative morbidity, the ability to rehabilitate or the mid-term survival are not addressed by these means. Recently there have been some reports that addition of physical performance testing to the standard prediction models may provide prognostic value. There is a wide scale of various physical performance and frailty tests that could be used for this purpose, but they have not been confronted with each other yet. Moreover, the postoperative physical rehabilitation has not been objectively assessed in larger scale despite the significant improvement in technology.

The hypothesisis of the study is that the preoperative outcomes of physical performance and frailty testing are able to predict the patient's reconvalescence after cardiac surgery in the short- and mid-term postoperatively. The aim is to analyze a set of tests with regard to their ability to predict postoperative reconvalescence, including the objective activity assessment (using Actigraph wGT3X-BT activity tracking device). Secondarily, the investigators aim to follow the patients up to 1 year postoperatively in terms of evaluating their mid-term outcomes.

Detailed Description

Detailed description of testing performed in the exact order as in the patient:

1. Body weight and body composition (weigth of fat, weigth of muscle) measurement using bioimpendance scale Tanita BC 545N.

2. Katz Index of Independence in Activites of Daily Living performed and assessed exactly as described elsewhere.

3. Hand-grip strength test using the Kern MAP 80K1 device. Modified Southhampton protocol will be used for the measurement: Patient is sitting on a chair without side arms, the elbows are in a right angle. The patient is instructed to squeeze the device as much as possible and hold for 3 seconds. He squeezes the device with the right hand, then with the left hand. This is performed two times with each hand in total. The highest measured value is recorded.

4. 5-meter gait test. Patient is instructed to walk the 5-meter line as fast as possible and the time is being measured. This is repeated three times. Average time of the three attempts is recorded.

5. 6-minute walk test. Patient is instructed to walk without interruption for 6 minutes in the corridor of department's standard ward (exactly 36 meters long). He walks there and back repeatedly and the walked distance is calculated with regard to the number of corridors walked.

6. During the last two tests patient is wearing a pulse oxymeter (Berry BM1000C) that is connected with investigator's smartphone (either Android or iOS) through bluetooth. Eventual latent respiratory failure is recorded, defined as a drop in peripheral saturation of 4 % and more, or under 88 %.

7. Pre-defined set of laboratory blood tests: haemoglobin, creatinin, albumin, TSH, free T3, free T4.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • informed patient consent
  • patient scheduled for an elective cardiac surgery. The following procedures are accepted: coronary artery bypass grafting (CABG) , single valve replacement (SVR), CABG + SVR, CABG + MAZE procedure, SVR + MAZE procedure
  • since June 2021, patients undergoing double-valve surgery have been allowed to be included in the study to promote patients inclusion
Exclusion Criteria
  • complex cardiac surgery (except the options listed above)
  • ejection fraction of the left ventricle < 30 % according to the last preoperative echocardiography
  • EuroSCORE II value > 5 %
  • urgent or emergent surgery
  • patient unable to walk and/or perform the test
  • severe dementia (due to unability to cooperate during the testing and follow-up)
  • re-do surgery
  • minimally invasive surgery (i.e. other than full median sternotomy)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Standard postoperative measures of patient reconvalescenceUsually up to 30 days postoperatively

To analyze the ability of preoperative physical performance and frailty tests to predict the standard postoperative measures of patient reconvalescence: length of artificial ventilation, length of stay in the intensive care unit, total postoperative hospital stay.

Objective postoperative patient activity trackingFirst 4 postoperative days in the standard ward

To analyze the ability of preoperative physical performance and frailty tests to predict the outcomes of objective postoperative patient activity tracking by the means of total number of steps taken during the first 4 days in the standard ward and total intensity of physical activity in this time period, both measured by the dedicated wearable Actigraph activity monitor.

Secondary Outcome Measures
NameTimeMethod
The dynamics of physical performance in the mid-term postoperatively1 year postoperatively

To repeat the set of preoperative physical and frailty tests in pre-specified time intervals after the surgery: on 7th postoperative day, 3 months after the surgery and 1 year after the surgery. Thereafter, the investigators aim to evaluate the dynamics of the outcomes and eventual predictive value of the preoperative outcomes.

Mid-term postoperative mortality, major adverse events, cardiac rehospitalizations1 year postoperatively

To analyze the ability of preoperative physical performance and frailty tests to predict the 1-year (mid-term) postoperative mortality, major adverse cardiac and cerebrovascular events and the risk of rehospitalizations for cardiac reasons.

Trial Locations

Locations (1)

University Hospital Hradec Králové

🇨🇿

Hradec Králové, Královehradecký Kraj, Czechia

© Copyright 2025. All Rights Reserved by MedPath